Angelos Hatzakis
Angelos Hatzakis
Professor of Epidemiology and Preventive Medicine-National and Kapodistrian University of Athens
Verified email at
Cited by
Cited by
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
Financial crisis, austerity, and health in Europe
M Karanikolos, P Mladovsky, J Cylus, S Thomson, S Basu, D Stuckler, ...
The lancet 381 (9874), 1323-1331, 2013
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
A proposed system for the nomenclature of hepatitis C viral genotypes
P Simmonds, A Alberti, HJ Alter, F Bonino, DW Bradley, C Brechot, ...
Hepatology 19 (5), 1321-1324, 1994
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
GR Simpson, TF Schulz, D Whitby, PM Cook, C Boshoff, L Rainbow, ...
The Lancet 348 (9035), 1133-1138, 1996
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ...
The Journal of infectious diseases 192 (6), 958-966, 2005
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel
V Soriano, M Puoti, M Sulkowski, A Cargnel, Y Benhamou, M Peters, ...
Aids 21 (9), 1073-1089, 2007
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV)
ME Eyster, HJ Alter, LM Aledort, S Quan, A Hatzakis, JJ Goedert
Annals of Internal Medicine 115 (10), 764-768, 1991
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study
TR O'Brien, WA Blattner, D Waters, ME Eyster, MW Hilgartner, AR Cohen, ...
Jama 276 (2), 105-110, 1996
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
V Soriano, M Sulkowski, C Bergin, A Hatzakis, P Cacoub, C Katlama, ...
Aids 16 (6), 813-828, 2002
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma
C Boschoff, D Whitby, T Hatziionnou, C Fisher, J van der Walt, A Hatzakis, ...
The Lancet 345 (8956), 1043-1044, 1995
Management of antiviral resistance in patients with chronic hepatitis B
S Locarnini, A Hatzakis, J Heathcote, EB Keeffe, TJ Liang, D Mutimer, ...
Antiviral therapy 9 (5), 679-693, 2004
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference
A Hatzakis, S Wait, J Bruix, M Buti, M Carballo, M Cavaleri, M Colombo, ...
Journal of viral hepatitis 18, 1-16, 2011
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach
JM Pawlotsky, G Dusheiko, A Hatzakis, D Lau, G Lau, TJ Liang, ...
Gastroenterology 134 (2), 405-415, 2008
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs
S Locarnini, A Hatzakis, DS Chen, A Lok
Journal of hepatology 62 (1), S76-S86, 2015
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ...
The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial
AN Phillips, A Carr, J Neuhaus, F Visnegarwala, R Prineas, WJ Burman, ...
Antiviral therapy 13 (2), 177-188, 2008
The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis
G Magiorkinis, E Magiorkinis, D Paraskevis, SYW Ho, B Shapiro, ...
PLoS medicine 6 (12), e1000198, 2009
The system can't perform the operation now. Try again later.
Articles 1–20